Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a (118 visite)
Clin Immunol (ISSN: 1521-6616), 2017 Oct; 183: 249-253.
Tipo di articolo: Journal Article, Research Support, Non-U. S. Gov'T,
Impact factor: 3.557, Impact factor a 5 anni: 3.93
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030456724&doi=10.1016%2fj.clim.2017.08.011&partnerID=40&md5=2ebeca68413650b4f66ce4dacd051472
Parole chiave: Adjuvants, Immunologic Therapeutic Use , Biomarkers Blood , Humans , Interferon Beta-1a Therapeutic Use , Multiple Sclerosis, Relapsing-Remitting Blood Drug Therapy , Predictive Value Of Tests , Transcriptome Immunology , Autoimmunity , Ifn-Beta-1a , Il-6 , Leptin, Beta1a Interferon, Biological Marker, Cd40 Ligand, Interleukin 6, Monocyte Chemotactic Protein 1, Tumor Necrosis Factor Receptor, Immunological Adjuvant, Adult, Article, Body Mass, Clinical Article, Clinical Feature, Clinical Outcome, Clinical Practice, Corticosteroid Therapy, Disease Activity, Disease Association, Disease Course, Disease Duration, Disease Severity, Drug Formulation, Female, Follow Up, Immunoassay, Nuclear Magnetic Resonance Imaging, Priority Journal, Recurrence Risk, Risk Factor,
Affiliazioni:
*** IBB - CNR ***
Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche, Universita degli Studi di Napoli "Federico II", Napoli, Italy.
Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Napoli, Italy.
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Napoli, Italy.
Dipartimento di Sanita Pubblica, Universita degli Studi di Napoli "Federico II", Napoli, Italy.
Dipartimento di Biologia, Universita degli Studi di Napoli "Federico II", Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita degli Studi di Napoli "Federico II", Napoli, Italy. Electronic address: giuseppe.matarese@unina.it.
Riferimenti:
Lublin, F.D., Reingold, S.C., Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Neurology, 46, pp. 907-91
Nylander, A., Hafler, D.A., Multiple sclerosis (2012) J. Clin. Invest., 122, pp. 1180-1188
Procaccini, C., Carbone, F., Di Silvestre, D., The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements (2016) Immunity, 44, pp. 406-421
Zeng, H., Chi, H., Metabolic control of regulatory T cell development and function (2015) Trends Immunol., 36, pp. 3-12
Carbone, F., La Rocca, C., De Candia, P., Metabolic control of immune tolerance in health and autoimmunity (2016) Semin. Immunol., 28, pp. 491-504
Palavra, F., Almeida, L., Ambrósio, A.F., Reis, F., Obesity and brain inflammation: a focus on multiple sclerosis (2016) Obes. Rev., 17, pp. 211-224
Emamgholipour, S., Eshaghi, S.M., Hossein-nezhad, A., Mirzaei, K., Maghbooli, Z., Sahraian, M.A., Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease (2013) PLoS One, 8
Matarese, G., Carrieri, P.B., La Cava, A., Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25 + regulatory T cells (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 5150-5155
Carbone, F., De Rosa, V., Carrieri, P.B., Regulatory T cell proliferative potential is impaired in human autoimmune disease (2014) Nat. Med., 20, pp. 69-74
Munger, K.L., Chitnis, T., Ascherio, A., Body size and risk of MS in two cohorts of US women (2009) Neurology, 73, pp. 1543-1550
Mokry, L.E., Ross, S., Timpson, N.J., Sawcer, S., Davey Smith, G., Richards, J.B., Obesity and Multiple Sclerosis: a Mendelian Randomization Study (2016) PLoS Med., 13
Hedström, A.K., Lima Bomfim, I., Barcellos, L., Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis (2014) Neurology, 82, pp. 865-872
Carrieri, P.B., Carbone, F., Perna, F., Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate (2015) Metabolism, 64, pp. 1112-1121
Poser, C.M., Brinar, V.V., Diagnostic criteria for multiple sclerosis (2001) Clin. Neurol. Neurosurg., 103, pp. 1-11
Polman, C.H., Reingold, S.C., Banwell, B., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria (2011) Ann. Neurol., 69, pp. 292-302
Kurtzke, J.F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) (1983) Neurology, 33, pp. 1444-1452
Scarpini, E., Galimberti, D., Baron, P., IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease (2002) J. Neurol. Sci., 195, pp. 41-46
Franciotta, D., Martino, G., Zardini, E., Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies (2001) J. Neuroimmunol., 115, pp. 192-198
Samoilova, E.B., Horton, J.L., Hilliard, B., Liu, T.S., Chen, Y., IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells (1998) J. Immunol., 161, pp. 6480-6486
Serada, S., Fujimoto, M., Mihara, M., IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 9041-9046
Chen, Y.C., Yang, X., Miao, L., Serum level of interleukin-6 in Chinese patients with multiple sclerosis (2012) J. Neuroimmunol., 249, pp. 109-111
Matarese, G., Di Giacomo, A., Sanna, V., Requirement for leptin in the induction and progression of autoimmune encephalomyelitis (2001) J. Immunol., 166, pp. 5909-5916
Sanna, V., Di Giacomo, A., La Cava, A., Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses (2003) J. Clin. Invest., 111, pp. 241-250
De Rosa, V., Procaccini, C., La Cava, A., Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis (2006) J. Clin. Invest., 116, pp. 447-455
Batocchi, A.P., Rotondi, M., Caggiula, M., Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta (2003) J. Neuroimmunol., 139, pp. 150-154
Poggi, M., Jager, J., Paulmyer-Lacroix, O., The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes (2009) Diabetologia, 52, pp. 1152-1163
Chatzigeorgiou, A., Phieler, J., Gebler, J., Bornstein, S.R., Chavakis, T., CD40L stimulates the crosstalk between adipocytes and inflammatory cells (2013) Horm. Metab. Res., 45, pp. 741-747
Burman, J., Svensson, E., Fransson, M., The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention (2014) J. Neuroimmunol., 277, pp. 153-159
Kato, K., Santana-Sahagún, E., Rassenti, L.Z., The soluble CD40 ligand sCD154 in systemic lupus erythematosus (1999) J. Clin. Invest., 104, pp. 947-955
Khoury, S.J., Orav, E.J., Guttmann, C.R., Kikinis, R., Jolesz, F.A., Weiner, H.L., Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis (1999) Neurology, 53, pp. 758-764
Van Oosten, B.W., Barkhof, F., Truyen, L., Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 (1996) Neurology, 47, pp. 1531-1534
Praksova, P., Stourac, P., Bednarik, J., Vlckova, E., Mikulkova, Z., Michalek, J., Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations (2012) J. Neurol. Sci., 319, pp. 18-23
Longhini, A.L., von Glehn, F., Brandão, C.O., Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse (2011) J. Neuroinflammation, 8, p. 2
Durelli, L., Conti, L., Clerico, M., T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta (2009) Ann. Neurol., 65, pp. 499-509
Clin Immunol (ISSN: 1521-6616), 2017 Oct; 183: 249-253.
Tipo di articolo: Journal Article, Research Support, Non-U. S. Gov'T,
Impact factor: 3.557, Impact factor a 5 anni: 3.93
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030456724&doi=10.1016%2fj.clim.2017.08.011&partnerID=40&md5=2ebeca68413650b4f66ce4dacd051472
Parole chiave: Adjuvants, Immunologic Therapeutic Use , Biomarkers Blood , Humans , Interferon Beta-1a Therapeutic Use , Multiple Sclerosis, Relapsing-Remitting Blood Drug Therapy , Predictive Value Of Tests , Transcriptome Immunology , Autoimmunity , Ifn-Beta-1a , Il-6 , Leptin, Beta1a Interferon, Biological Marker, Cd40 Ligand, Interleukin 6, Monocyte Chemotactic Protein 1, Tumor Necrosis Factor Receptor, Immunological Adjuvant, Adult, Article, Body Mass, Clinical Article, Clinical Feature, Clinical Outcome, Clinical Practice, Corticosteroid Therapy, Disease Activity, Disease Association, Disease Course, Disease Duration, Disease Severity, Drug Formulation, Female, Follow Up, Immunoassay, Nuclear Magnetic Resonance Imaging, Priority Journal, Recurrence Risk, Risk Factor,
Affiliazioni:
*** IBB - CNR ***
Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche, Universita degli Studi di Napoli "Federico II", Napoli, Italy.
Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Napoli, Italy.
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Napoli, Italy.
Dipartimento di Sanita Pubblica, Universita degli Studi di Napoli "Federico II", Napoli, Italy.
Dipartimento di Biologia, Universita degli Studi di Napoli "Federico II", Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita degli Studi di Napoli "Federico II", Napoli, Italy. Electronic address: giuseppe.matarese@unina.it.
Riferimenti:
Lublin, F.D., Reingold, S.C., Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Neurology, 46, pp. 907-91
Nylander, A., Hafler, D.A., Multiple sclerosis (2012) J. Clin. Invest., 122, pp. 1180-1188
Procaccini, C., Carbone, F., Di Silvestre, D., The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements (2016) Immunity, 44, pp. 406-421
Zeng, H., Chi, H., Metabolic control of regulatory T cell development and function (2015) Trends Immunol., 36, pp. 3-12
Carbone, F., La Rocca, C., De Candia, P., Metabolic control of immune tolerance in health and autoimmunity (2016) Semin. Immunol., 28, pp. 491-504
Palavra, F., Almeida, L., Ambrósio, A.F., Reis, F., Obesity and brain inflammation: a focus on multiple sclerosis (2016) Obes. Rev., 17, pp. 211-224
Emamgholipour, S., Eshaghi, S.M., Hossein-nezhad, A., Mirzaei, K., Maghbooli, Z., Sahraian, M.A., Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease (2013) PLoS One, 8
Matarese, G., Carrieri, P.B., La Cava, A., Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25 + regulatory T cells (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 5150-5155
Carbone, F., De Rosa, V., Carrieri, P.B., Regulatory T cell proliferative potential is impaired in human autoimmune disease (2014) Nat. Med., 20, pp. 69-74
Munger, K.L., Chitnis, T., Ascherio, A., Body size and risk of MS in two cohorts of US women (2009) Neurology, 73, pp. 1543-1550
Mokry, L.E., Ross, S., Timpson, N.J., Sawcer, S., Davey Smith, G., Richards, J.B., Obesity and Multiple Sclerosis: a Mendelian Randomization Study (2016) PLoS Med., 13
Hedström, A.K., Lima Bomfim, I., Barcellos, L., Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis (2014) Neurology, 82, pp. 865-872
Carrieri, P.B., Carbone, F., Perna, F., Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate (2015) Metabolism, 64, pp. 1112-1121
Poser, C.M., Brinar, V.V., Diagnostic criteria for multiple sclerosis (2001) Clin. Neurol. Neurosurg., 103, pp. 1-11
Polman, C.H., Reingold, S.C., Banwell, B., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria (2011) Ann. Neurol., 69, pp. 292-302
Kurtzke, J.F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) (1983) Neurology, 33, pp. 1444-1452
Scarpini, E., Galimberti, D., Baron, P., IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease (2002) J. Neurol. Sci., 195, pp. 41-46
Franciotta, D., Martino, G., Zardini, E., Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies (2001) J. Neuroimmunol., 115, pp. 192-198
Samoilova, E.B., Horton, J.L., Hilliard, B., Liu, T.S., Chen, Y., IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells (1998) J. Immunol., 161, pp. 6480-6486
Serada, S., Fujimoto, M., Mihara, M., IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 9041-9046
Chen, Y.C., Yang, X., Miao, L., Serum level of interleukin-6 in Chinese patients with multiple sclerosis (2012) J. Neuroimmunol., 249, pp. 109-111
Matarese, G., Di Giacomo, A., Sanna, V., Requirement for leptin in the induction and progression of autoimmune encephalomyelitis (2001) J. Immunol., 166, pp. 5909-5916
Sanna, V., Di Giacomo, A., La Cava, A., Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses (2003) J. Clin. Invest., 111, pp. 241-250
De Rosa, V., Procaccini, C., La Cava, A., Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis (2006) J. Clin. Invest., 116, pp. 447-455
Batocchi, A.P., Rotondi, M., Caggiula, M., Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta (2003) J. Neuroimmunol., 139, pp. 150-154
Poggi, M., Jager, J., Paulmyer-Lacroix, O., The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes (2009) Diabetologia, 52, pp. 1152-1163
Chatzigeorgiou, A., Phieler, J., Gebler, J., Bornstein, S.R., Chavakis, T., CD40L stimulates the crosstalk between adipocytes and inflammatory cells (2013) Horm. Metab. Res., 45, pp. 741-747
Burman, J., Svensson, E., Fransson, M., The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention (2014) J. Neuroimmunol., 277, pp. 153-159
Kato, K., Santana-Sahagún, E., Rassenti, L.Z., The soluble CD40 ligand sCD154 in systemic lupus erythematosus (1999) J. Clin. Invest., 104, pp. 947-955
Khoury, S.J., Orav, E.J., Guttmann, C.R., Kikinis, R., Jolesz, F.A., Weiner, H.L., Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis (1999) Neurology, 53, pp. 758-764
Van Oosten, B.W., Barkhof, F., Truyen, L., Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 (1996) Neurology, 47, pp. 1531-1534
Praksova, P., Stourac, P., Bednarik, J., Vlckova, E., Mikulkova, Z., Michalek, J., Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations (2012) J. Neurol. Sci., 319, pp. 18-23
Longhini, A.L., von Glehn, F., Brandão, C.O., Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse (2011) J. Neuroinflammation, 8, p. 2
Durelli, L., Conti, L., Clerico, M., T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta (2009) Ann. Neurol., 65, pp. 499-509
Reliable immunologic biomarkers able to monitor disease course during <br>multiple sclerosis (MS) are still missing. We aimed at identifying <br>possible immunometabolic biomarkers able to predict the clinical outcome<br> in MS patients during treatment with interferon (IFN)-beta-1a. We <br>measured in 45 relapsing-remitting (RR) MS patients, blood circulating <br>levels of several immunometabolic markers, at enrolment, and correlated <br>their levels to disease activity and progression over time. Higher <br>levels of interleukin (IL)-6, soluble-CD40-ligand (sCD40L) and leptin at<br> baseline associated with a higher relapse rate and a greater risk of <br>experiencing at least one relapse in the following year. Higher values <br>of soluble tumor necrosis factor receptor (sTNF-R) and leptin at <br>baseline were predictive of a higher number of lesions in the following <br>one-year of follow up. In conclusion, our data suggest that an <br>immunometabolic profiling measuring IL-6, sCD40L, leptin and sTNF-R at <br>baseline, could represent a useful tool to predict disease course in <br>RRMS patients during treatment with IFN-beta-1a.
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Gandhi S, Marr K, Mancini M, Caprio MG, Jakimovski D, Chandra A, Hagemeier J, Hojnacki D, Kolb C, Weinstock-guttman B, Zivadinov R
* No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years (48 visite)
Bmc Neurol (ISSN: 1471-2377linking), 2019 Jun 11; 19(1): 121-121.
Impact Factor: 2.17
Dettagli Esporta in BibTeX Esporta in EndNote
Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M
* Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment (108 visite)
J Neurol (ISSN: 1432-1459electronic, 0340-5354linking, 0340-5354print), 2019 Feb; 266(2): 361-368.
Impact Factor: 3.853
Dettagli Esporta in BibTeX Esporta in EndNote
Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A
* MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis (137 visite)
Neuroradiology (ISSN: 0028-3940linking, 1432-1920electronic), 2019 Feb; 61(2): 155-162.
Impact Factor: 1.287
Dettagli Esporta in BibTeX Esporta in EndNote
Pontillo G, Cocozza S, Lanzillo R, Russo C, Stasi MD, Paolella C, Vola EA, Criscuolo C, Borrelli P, Palma G, Tedeschi E, Morra VB, Elefante A, Brunetti A
* Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study (82 visite)
Am J Neuroradiol (ISSN: 0195-6108linking, 1936-959xelectronic), 2019 Jan; 40(1): 99-106.
Impact Factor: 3.55
Dettagli Esporta in BibTeX Esporta in EndNote
Arotenuto A, Cocozza S, Quarantelli M, Arcara G, Lanzillo R, Brescia Morra V, Cerillo I, Tedeschi E, Orefice G, Bambini V, Brunetti A, Iodice R
* Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction (166 visite)
Brain Lang (ISSN: 0093-934xlinking), 2018 Oct; 185: 47-53.
Impact Factor: 2.851
Dettagli Esporta in BibTeX Esporta in EndNote
Ugga L, Romeo V, Tedeschi E, Brunetti A, Quarantelli M
* Superparamagnetic iron oxide nanocolloids in MRI studies of neuroinflammation (98 visite)
J Neurosci Methods (ISSN: 0165-0270linking, 1872-678xelectronic), 2018 Jun 18; 310: 12-23.
Impact Factor: 2.668
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi E, Cocozza S, Borrelli P, Ugga L, Morra VB, Palma G
* Longitudinal assessment of dentate nuclei relaxometry during massive gadobutrol exposure (99 visite)
Magn Reson Med Sci (ISSN: 1347-3182), 2018; 17(1): 100-104.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Jakimovski D, Marr K, Mancini M, Caprio MG, Gandhi S, Bergsland N, Paunkoski I, Hagemeier J, Chandra A, Weinstock-guttman B, Zivadinov R
* Global and regional brain atrophy is associated with low or retrograde facial vein flow in multiple sclerosis (114 visite) (PDF 104 visite)
Veins And Lymphatics, 2017 Sep; 6: N/D-N/D.
Impact Factor: 1.143
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Marr K, Gandhi S, Jakimovski D, Hagemeier J, Weinstock-guttman B, Zivadinov R, Mancini M
* Centralized and local color Doppler ultrasound reading agreement for diagnosis of the chronic cerebrospinal venous insufficiency in patients with Multiple Sclerosis (130 visite)
Curr Neurovasc Res (ISSN: 1567-2026), 2017 Jul 17; N/D: N/D-N/D.
Impact Factor: 1.716
Dettagli Esporta in BibTeX Esporta in EndNote
Pontillo G, Cocozza S, Lanzillo R, Borrelli P, De Rosa A, Brescia Morra V, Tedeschi E, Palma G
* Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study (103 visite)
Front Neurol (ISSN: 1664-2295, 1664-2295linking, 1664-2295print), 2017 Jun 19; 8: 294-294.
Impact Factor: 3.508
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Carotenuto A, Pivonello C, Moccia M, Cianflone A, Marsili A, Puorro G, Sacca F, Russo CV, De Luca Picione C, Ausiello F, Colao A, Brescia Morra V
* Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon beta-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis (131 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2017 Feb; 24(2): 446-449.
Impact Factor: 4.621
Dettagli Esporta in BibTeX Esporta in EndNote
Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V
* Grey: white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression (174 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2017 Jan; 24(1): 195-204.
Impact Factor: 4.621
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Mancini M
* Vascular Disease in Multiple Sclerosis: A Real Thing? (126 visite) (PDF 133 visite)
Blood Disorders & Transfusion, 2016 Oct; 7: N/D-N/D.
Impact Factor: 0.486
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Quarantelli M, Pozzilli C, Trojano M, Amato MP, Marrosu MG, Francia A, Florio C, Orefice G, Tedeschi G, Bellantonio P, Annunziata P, Grimaldi LM, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Brescia Morra V
* No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon beta1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) (304 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970), 2016 Aug; 22(9): 1163-1173.
Impact Factor: 4.84
Dettagli Esporta in BibTeX Esporta in EndNote
Cocozza S, Canna A, Lanzillo R, Russo C, Postiglione E, Liuzzi R, Vastola M, Brunetti A, Salvatore M, Brescia Morra V, Palma G, Tedeschi E
* Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study (154 visite)
The British Institute Of Radiology, 2016 Jun; N/D: N/D-N/D.
Impact Factor: 1.84
Dettagli Esporta in BibTeX Esporta in EndNote
Criscuolo C, Lanzillo R, Cianflone A, Liuzzi R, Mancini M, Tedeschi E, Postiglione E, Vacca G, Vacchiano V, Moccia M, Puorro G, Marsili A, Incoronato M, Salvatore M, Brescia Morra V
* Endothelin-1 as a candidate cerebrovascular biomarker in Multiple Scelrosis (138 visite) (PDF 130 visite)
Ectrims - Poster, 2016 Apr; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Gandhi S, Mancini M, Marr K, Caprio MG, Jakimovski D, Chandra A, Hagemeier J, Weinstock-guttman B, Zivadinov R
* No association of extra-cranial neous abnormalities and clinical outcomes in multiple sclerosis patients over 5 years (139 visite)
6th Annual Meeting Of The International Society For Neurovascular Disease, 2016 Apr; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi E, Palma G, Canna A, Cocozza S, Russo C, Borrelli P, Lanzillo R, Angelini V, Postiglione E, Morra VB, Salvatore M, Brunetti A, Quarantelli M
* In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents (185 visite)
Eur Radiol (ISSN: 0938-7994, 1432-1084electronic), 2016 Feb 23; 26(12): 4577-4584.
Impact Factor: 3.967
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Chiodi A, Carotenuto A, Magri V, Napolitano A, Liuzzi R, Costabile T, Rainone N, Freda MF, Valerio P, Brescia Morra V
* Quality of life and cognitive functions in early onset multiple sclerosis (174 visite)
Eur J Paediatr Neuro (ISSN: 1090-3798, 1532-2130), 2016 Jan; 20(1): 158-163.
Impact Factor: 2.013
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Russo C, Giugliano A, Ragucci M, Mancini M
* Vascular Disease in Patients with Multiple Sclerosis: A Review (161 visite) (PDF 127 visite)
J Vasc Med Surg, 2016; 4: 1-12.
Impact Factor: 0.163
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Tedeschi E, Borrelli P, Cocozza S, Russo C, Liu S, Ye Y, Comerci M, Alfano B, Salvatore M, Haacke EM, Mancini M
* A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain (366 visite) (PDF 195 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2015 Aug 18; 10(8): e0134963-e0134963.
Impact Factor: 3.057
Dettagli Esporta in BibTeX Esporta in EndNote
Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-kingshott CA, Tozer DJ, Macmanus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT
* Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study (87 visite)
Neurology (ISSN: 0028-3878linking, 1526-632x), 2015 Mar 17; 84 (11 ): 1145-1152.
Impact Factor: 5.065
Dettagli Esporta in BibTeX Esporta in EndNote
Postiglione E, Criscuolo C, Cianflone A, Lanzillo R, Mancini M, Tedeschi E, Liuzzi R, Vacca G, Vastola M, Capasso M, Mancino T, Mormile R, Passannanti A, Palma G, Caprio M, Incoronato M, Salvatore M, Brescia-Morra V
* AN INTERIM ANALYSIS ON SUSCEPTIBILITY TO VASCULAR ALTERATIONS IN MS AND ALS (207 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 21-22.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Canna A, Palma G, Tedeschi E, Cocozza S, Lanzillo R, Russo C, Borrelli P, Postiglione E, Liuzzi R, Criscuolo C, Brescia-Morra V, Mancini M, Salvatore M
* ASSESSING THE CORRELATION BETWEEN IRON DEPOSIT IN THE BASAL GANGLIA AND FLOW ABNORMALITIES IN THE NECK VEINS WITH MRI: PRELIMINARY EXPERIENCE (177 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 20-21.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cervo A, Caprio MG, Ragucci M, Mancini M
* CEREBRAL CIRCULATION IN PATIENTS WITH MULTIPLE SCLEROSIS. A COLOR-DOPPLER STUDY OF EXTRACRANIAL ARTERIAL AND VENOUS VESSELS (152 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 12-12.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cocozza S, Canna A, Lanzillo R, Palma G, Postiglione E, Russo C, Borrelli P, Brescia Morra V, Brunetti A, Salvatore M, Tedeschi E
* Correlation between Neck Venous Drainage and Multiple Sclerosis (149 visite)
Rsna 101st Scientific Assembly And Annual Meeting, 2015; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cianflone A, Criscuolo C, Lanzillo R, Liuzzi R, Mancini M, Tedeschi E, Postiglione E, Vacca G, Vacchiano V, Moccia M, VastoLa M, Puorro G, Marsili A, Incoronato M, Salvatore M, Brescia-Morra V
* INCREASED ENDOTHELIN-1 SERUM LEVELS IN PATIENTS WITH MULTIPLE SCLEROSIS (235 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 22-22.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, Lanzillo R, Vacchiano V, Realmuto S, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Montella P, Morra VB, Savettieri G, Alfano B, Gallo A, Simone I, Viterbo R, Zappia M, Bonavita S, Tedeschi G
* Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients (226 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2015; 10(3): N/D-N/D.
Impact Factor: 3.057
Dettagli Esporta in BibTeX Esporta in EndNote
Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Brescia Morra V, De Michele G
* SPG5 and multiple sclerosis: Clinical and genetic overlap? (153 visite)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2015; 133(6): 410-414.
Impact Factor: 2.559
Dettagli Esporta in BibTeX Esporta in EndNote
Moccia M, Erro R, Montella S, Carotenuto A, Pappata S, Orefice G
* Diagnostic challenges of Parkinsonism occurring in multiple sclerosis (124 visite)
Acta Neurol Belg (ISSN: 0300-9009), 2014 Oct 12; 115(3): 513-515.
Impact Factor: 0.894
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
* JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level (149 visite)
Ther Clin Risk Manag (ISSN: 1178-203x), 2014 Oct 9; 10: 807-814.
Impact Factor: 1.469
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Quarantelli M, Veria V, Orefice G, Marrosu MG, Trojano M, Amato MP, Francia AM, Florio C, Tedeschi G, Bellantonio P, Annunziata P, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Pozzilli C, Morra VB
* Brain atrophy in relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study) (227 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2014 May; 21(S.I.Suppl.1): 58-58.
Impact Factor: 4.055
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi E, Lanzillo R, Mancini M, Russo C, Cianflone A, Liuzzi R, Cocozza S, Postiglione E, Palma G, Caprio MG, Incoronato MR, Criscuolo C, Brescia Morra V, Salvatore M
* Imaging Of Brain Perfusion In Multiple Sclerosis And Neurodegenerative Diseases: Association With Endothelial Factors. An Interim Analysis (185 visite) (PDF 152 visite)
2014 Joint Actrims-Ectrims Meeting, 2014 Apr 28; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Lanzillo R, Liuzzi R, Di Donato O, Ragucci M, Monti S, Salvatore E, Morra VB, Salvatore M
* Internal jugular vein blood flow in multiple sclerosis patients and matched controls (194 visite) (PDF 148 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Mar 27; 9(3): e92730-e92730.
Impact Factor: 3.234
Dettagli Esporta in BibTeX Esporta in EndNote
Lavorgna L, Bonavita S, Ippolito D, Lanzillo R, Salemi G, Patti F, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Bresciamorra V, Savettieri G, Zappia M, Alfano B, Gallo A, Simone I, Tedeschi G
* Clinical And Magnetic Resonance Imaging Predictors Of Disease Progression In Multiple Sclerosis: A Nine-Year Follow-Up Study (249 visite) (PDF 175 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970), 2014 Feb; 20(2): 220-226.
Impact Factor: 4.822
Dettagli Esporta in BibTeX Esporta in EndNote
Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M
* Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS (179 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 0028-3878linking), 2014 Jan 7; 82(1): 41-48.
Impact Factor: 8.185
Dettagli Esporta in BibTeX Esporta in EndNote
Clerico M, De Mercanti S, Versino E, Piazza F, Gned D, Brescia Morra V, Lanzillo R, Amato L, Quarantelli M, Ghezzi A, Bianchi A, Baroncini D, Salemi G, Realmuto S, Ferro MT, Vitetta F, Donghia M, Paolicelli D, Trojano M, Durelli L
* Management of multiple sclerosis patients after the 24th Natalizumab course: the Ty-STOP study (155 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2013 Oct; 19(11): N/D-N/D.
Impact Factor: 4.863
Dettagli Esporta in BibTeX Esporta in EndNote
Comi G, Battaglia MA, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G, Salvetti M, Sormani MP, Tesio L, Stolz E, Zaratin P, Mancardi G, Mancini M
* Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study (136 visite)
Mult Scler (ISSN: 1477-0970, 1352-4585, 1352-4585linking), 2013 Oct; 19(11): 1508-1517.
Impact Factor: 4.863
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V
* Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice (136 visite)
Neurol Sci (ISSN: 1590-1874, 1590-0187, 1590-3478), 2013 Apr; 34(4): 521-528.
Impact Factor: 0.38
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Mancini M, Liuzzi R, Di Donato O, Salvatore E, Maglio V, Vacca G, Amato L, D'Anna G, Brunetti A, Brescia Morra V
* Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon (197 visite)
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2013 Feb 13; 13: 20-20.
Impact Factor: 2.486
Dettagli Esporta in BibTeX Esporta in EndNote
Comi G, Battaglia MA, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G, Salvetti M, Sormani MP, Tesio L, Stolz E, Mancardi G, Mancini M
* Italian Multicentre Observational Study Of The Prevalence Of Ccsvi In Multiple Sclerosis (cosmo Study): Rationale, Design, And Methodology (131 visite)
Neurol Sci, 2013 Jan; N/D: N/D-N/D.
Impact Factor: 1.362
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Quarantelli M, Bonavita S, Ventrella G, Lus G, Vacca G, Prinster A, Orefice G, Tedeschi G, Brescia Morra V
* Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: A head-to-head retrospective study (173 visite)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2012 Nov; 126(5): 306-314.
Impact Factor: 2.474
Dettagli Esporta in BibTeX Esporta in EndNote
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
* Efficacy, Safety And Tolerability Of Atorvastatin In Patients With Relapsing-Remitting Multiple Sclerosis In Treatment With Interferon-Beta (arianna): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group-Study, Lyon. France (224 visite)
Proceedings Of The 23rd Ectrims Meeting Lyon France, 2012 Oct 10; AbstractBook: 477-477.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
* Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study (207 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2012 Oct; 18: 197-197.
Impact Factor: 4.472
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Morra VB, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Salvatore E, Brunetti A, Iaccarino V, Salvatore M
* Multiple sclerosis: cerebral circulation time (165 visite)
Radiology (ISSN: 1527-1315, 0033-8419, 1527-1315electronic), 2012 Mar; 262(3): 947-955.
Impact Factor: 6.339
Dettagli Esporta in BibTeX Esporta in EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (317 visite)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Brescia Morra V, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Brunetti A, Salvatore M
* Contrast-Enhanced Ultrasound Evaluation Of The Cerebral Circulation Time In Patients With Multiple Sclerosis (131 visite)
J Ultrasound Med, 2012; N/D: 49-49.
Impact Factor: 1.532
Dettagli Esporta in BibTeX Esporta in EndNote
Malferrari G, Del Sette M, Zedde M, Sanguigni S, Carraro C, Baracchini C, Mancini M, Stolz E
* Italian multicenter study on venous hemodynamics in multiple sclerosis: Advanced Sonological Protocol (169 visite)
Perspect Med (ISSN: 2211-968x), 2012; 1-12: 399-403.
Impact Factor: 1.132
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Gasperi M, Prinster A, Vacca G, Pivonello C, Orefice G, Colao A, Morra VB
* Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients (170 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2011 Dec; 18(12): 1402-1406.
Impact Factor: 3.692
Dettagli Esporta in BibTeX Esporta in EndNote
Bastianello S, Romani A, Viselner G, Tibaldi EC, Giugni E, Altieri M, Cecconi P, Mendozzi L, Farina M, Mariani D, Galassi A, Quattrini C, Mancini M, Brescia VM, Lagace A, Mcdonald S, Bono G, Bergamaschi R
* Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study (148 visite)
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2011 Oct 26; 11: 132-132.
Impact Factor: 2.167
Dettagli Esporta in BibTeX Esporta in EndNote
Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F, COGIMUS
* Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study (163 visite) (PDF 154 visite)
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2011 Oct 14; 11: 125-125.
Impact Factor: 2.167
Dettagli Esporta in BibTeX Esporta in EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (274 visite)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Comerci M, Larobina M, Prinster A, Hornak JP, Selvan SE, Amato U, Quarantelli M, Tedeschi G, Brunetti A, Salvatore M
* An MRI digital brain phantom for validation of segmentation methods (277 visite) (PDF 559 visite)
Med Image Anal (ISSN: 1361-8415, 1361-8423, 1361-8415linking), 2011 Jun; 15(3): 329-339.
Impact Factor: 4.424
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Orefice G, Prinster A, Ventrella G, Liuzzi R, Scarano V, Florio C, Vacca G, Brunetti A, Alfano B, Brescia Morra V, Bonavita V
* Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy (130 visite) (PDF 139 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478), 2011 Apr; 32(2): 287-292.
Impact Factor: 1.315
Dettagli Esporta in BibTeX Esporta in EndNote
Dinacci D, Tessitore A, Russo AA, De Bonis ML, Lavorgna L, Picconi O, Sacco R, Bonavita S, Gallo A, Servillo G, Marcuccio L, Comerci M, Galletti P, Alfano B, Tedeschi G
* BDNF Val66Met polymorphism and brain volumes in multiple sclerosis (230 visite) (PDF 164 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Feb; 32(1): 117-123.
Impact Factor: 1.315
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Vacca G, Liuzzi R, Amato L, Orefice G, Colao A, Brescia Morra V
* Growth Hormone Axis In Early Multiple Sclerosis Patients Before And After 2 Years Treatment With Interferon Beta-1b - An Interim Analysis (145 visite)
Proceedings Of The Xlii Meeting Of The Italian Society Of Neurology, 2011; nd: 360-360.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Orefice G, Quarantelli M, Rinaldi C, Prinster A, Ventrella G, Spitaleri D, Lus G, Vacca G, Carotenuto B, Salvatore E, Brunetti A, Tedeschi G, Brescia Morra V
* Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial of combination therapy (188 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Apr; 16(4): 450-454.
Impact Factor: 4.23
Dettagli Esporta in BibTeX Esporta in EndNote
Prinster A, Quarantelli M, Lanzillo R, Orefice G, Vacca G, Carotenuto B, Alfano B, Brunetti A, Brescia Morra V, Salvatore M
* A voxel-based morphometry study of disease severity correlates in relapsing- remitting multiple sclerosis (194 visite) (PDF 142 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Jan; 16(1): 45-54.
Impact Factor: 4.23
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Gasperi M, Ventrella G, Prinster A, Vacca G, Orefice G, Colao A, Morra VB
* Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis (192 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2009 Sep; 15(9): 1402-1406.
Impact Factor: 3.279
Dettagli Esporta in BibTeX Esporta in EndNote
Dinacci D, Russo AA, Tessitore A, De Bonis ML, Lavorgna L, Picconi O, Sacco R, Bonavita S, Gallo A, Servillo G, Comerci M, Galletti P, Alfano B, Tedeschi G
* BDNF V4166Met Polymorphism and Brain Volumes in Multiple Sclerosis: A Relationship Still Debated (188 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
Dettagli Esporta in BibTeX Esporta in EndNote
Quarantelli M, Lanzillo R, Prinster A, Mollica C, Orefice G, Brunetti A, Vacca G, Salvatore M, Morra VB
* Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes (193 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B
* Brain atrophy evolution and lesion load accrual in multiple sclerosis: A 2-year follow-up study (255 visite) (PDF 182 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2009 Feb; 15(2): 204-211.
Impact Factor: 3.279
Dettagli Esporta in BibTeX Esporta in EndNote
Morra VB, Prinster A, Lanzillo R, Quarantelli M, Vacca G, Mollica C, Schiavone V, Brunetti A, Salvatore E, Alfano B, Orefice G
* Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population (205 visite) (PDF 142 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2008 Sep; 14: 45-54.
Impact Factor: 3.312
Dettagli Esporta in BibTeX Esporta in EndNote
Vicidomini C, Comerci M, Salvatore E, Quarantelli M, Varrone A, Evangelista L, Prinster A, Morra VB, Brunetti A, Salvatore M, Alfano B, Pappata S
* Combined Mri And Pet-18fdg Study In Patients With Primary Progressive (pp) And Relapsing Remitting (rr) Multiple Sclerosis (ms) (235 visite)
Abstract Book Of Dimi/Emil Annual Meeting 2008, 2008 Jun 1; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Orefice G, Quarantelli M, Lanzillo R, Brunetti A, Salvatore P, Prinster A, Vacca G, Mollica C, Bonavita V, Morra VB, Prinster A
* An open-label randomised clinical trial of atorvastatin in combination with IFN Beta 1a in active multiple sclerosis patients: preliminary results (177 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2008 Jun; 255: N/D-N/D.
Impact Factor: 2.536
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi G, Dinacci D, Lavorgna L, Prinster A, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Servillo G, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Paolillo A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone I, Salvatore M, Bonavita V, Alfano B
* Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability (240 visite) (PDF 163 visite)
J Neurol Sci (ISSN: 0022-510x), 2007 Dec 15; 263(1-2): 15-19.
Impact Factor: 2.315
Dettagli Esporta in BibTeX Esporta in EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (276 visite)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Brunetti A, De Pietro G, Esposito A
* An ontology approach for classification of abnormal white matter in patients with Multiple Sclerosis (222 visite) (PDF 178 visite)
Lecture Notes In Computer Science (ISSN: 0302-9743, 0302-974335404636319783540463634, 0302-974335402975459783540297543), 2007; 4799LNCS: 389-402.
Impact Factor: 0.302
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Prinster A, Scarano V, Liuzzi R, Coppola G, Florio C, Salvatore E, Schiavone V, Brunetti A, Muto M, Orefice G, Alfano B, Bonavita V, Brescia Morra V
* Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b (141 visite) (PDF 137 visite)
J Neurol Sci (ISSN: 0022-510x), 2006 Jun 15; 245(1-2): 141-145.
Impact Factor: 2.412
Dettagli Esporta in BibTeX Esporta in EndNote
Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, Salvatore E, Morra VB, Coppola G, Vacca G, Alfano B, Salvatore M
* Grey matter loss in relapsing-remitting multiple sclerosis: A voxel-based morphometry study (171 visite) (PDF 158 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2006 Feb 1; 29(3): 859-867.
Impact Factor: 5.559
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B
* Brain atrophy and lesion load in a large population of patients with multiple sclerosis (236 visite) (PDF 185 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2005 Jul 26; 65(2): 280-285.
Impact Factor: 5.065
Dettagli Esporta in BibTeX Esporta in EndNote
Morra VB, Quarantelli M, Lanzillo R, Prinster A, Coppola G, Brunetti A, Salvatore E, Mollica C, Orefice R, Liuzzi R, Alfano B, Orefice G
* Normal and abnormal brain tissue volumes and neuropsychological status in relapsing-remitting multiple sclerosis (159 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic, 1351-5101linking), 2004 Sep; 11: N/D-N/D.
Impact Factor: 2.225
Dettagli Esporta in BibTeX Esporta in EndNote
Morra V, Quarantelli M, Lanzillo R, Prinster A, Coppola G, Brunetti A, Salvatore E, Mollica C, Orefice R, Liuzzi R, Alfano B, Orefice G
* Normal and abnormal brain tissue volumes and neuropsychological status in relapsing-remitting multiple sclerosis (155 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2004 Jun; 251: N/D-N/D.
Impact Factor: 3.14
Dettagli Esporta in BibTeX Esporta in EndNote
Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A
* Brain tissue volume changes in relapsing-remitting multiple sclerosis: Correlation with lesion load (248 visite) (PDF 159 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2003 Feb; 18(2): 360-366.
Impact Factor: 6.192
Dettagli Esporta in BibTeX Esporta in EndNote
Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H
* Diffusion tensor imaging: Concepts and applications (209 visite)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic), 2001 Apr; 13(4): 534-546.
Impact Factor: 2.41
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Brunetti A, Larobina M, Quarantelli M, Tedeschi E, Ciarmiello A, Covelli EM, Salvatore M
Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis (272 visite) (PDF 537 visite)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic, 1053-1807linking), 2000 Dec; 12(6): 799-807.
Impact Factor: 1.302
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (284 visite) (PDF 504 visite)
Magn Reson Med (ISSN: 0740-3194, 1522-2594electronic), 1998 Mar; 39(3): 497-499.
Impact Factor: 2.962
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Brunetti A, Ciarmiello A, Covelli E, Larobina M, Salvatore M
Automated lesion identification and volumetric measurement of lesion load in multiple sclerosis using a multispectral relaxometric MR approach (140 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 1997 Nov; 205: N/D-N/D.
Impact Factor: 4.989
Dettagli Esporta in BibTeX Esporta in EndNote
Brunetti A, Tedeschi G, Di Costanzo A, Covelli EM, Aloj L, Bonavita S, Ciarmiello A, Alfano B, Salvatore M
White matter lesion detection in multiple sclerosis: Improved interobserver concordance with multispectral MRI display (200 visite) (PDF 155 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 1997 Sep; 244(9): 586-590.
Impact Factor: 1.976
Dettagli Esporta in BibTeX Esporta in EndNote
BRUNETTI A, TEDESCHI G, ALFANO B, DICOSTANZO A, ALOJ L, ARPAIA M, COVELLI E, BONAVITA S, SALVATORE M
Multiparametric characterization of lesions of the white matter in multiple sclerosis patients (147 visite)
Neuroradiology 1994, 1994; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Pozzilli C, Bernardi S, Mansi L, Picozzi P, Iannotti F, Alfano B, Bozzao L, Lenzi GL, Salvatore M, Conforti P
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography (146 visite) (PDF 165 visite)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 1988 Sep; 51(8): 1058-1062.
Impact Factor: 3.041
Dettagli Esporta in BibTeX Esporta in EndNote
Pota M, Esposito M, Megna R, De Pietro G, Quarantelli M, Brescia Morra V, Alfano B
Multivariate fuzzy analysis of brain tissue volumes and relaxation rates for supporting the diagnosis of relapsing-remitting multiple sclerosis (69 visite)
Biomedical Signal Processing And Control, N/D; 53: N/D-N/D.
Impact Factor: 2.943
Dettagli Esporta in BibTeX Esporta in EndNote
82 Records (58 escludendo Abstract e Conferenze).
Impact factor totale: 248.887 (199.035 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 268.072 (216.467 escludendo Abstract e Conferenze).
Impact factor totale: 248.887 (199.035 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 268.072 (216.467 escludendo Abstract e Conferenze).
Esporta in BibTeX Esporta in EndNote
Ultima modifica di Viviana De Rosa in data Friday 05 January 2018, 12:02:08
118 visite. Ultima visita in data Friday 24 January 2020, 11:23:56
ibb.cnr.it